General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation

Summary

This baseline-controlled, open-label, multicenter study evaluates the efficacy and safety of AJG555 orally administered for 2 weeks in pediatric participants with chronic constipation. The safety and efficacy of 12 weeks of administration will also be evaluated.

Timeline

Start

2016-11-15

Primary completion

2017-06-09

Completion

2017-08-04

Outcome

Met primary endpoint

release “小児を対象とした第Ⅲ相試験（ベースライン対照非盲検試験）においても、主要評価項目である自発排便回数は、投与前と比較して統計学的に有意な増加を示しました。” eapharma.co.jp ↗

Drugs

Indications